Citius Pharmaceuticals Inc (NASDAQ: CTXR) closed at $3.69 on Friday, up 2.5%. Its yearly range is $0.78 – $3.87. Inching closer to its all-time high, the biopharmaceutical company has a market capitalization of 499.90M USD. The company, which aims to create care products for cancer patients, has recently appointed Dr. […]
